April 6 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO
* Aurinia announces development plans for Voclosporin in Europe and Japan
* Aurinia Pharmaceuticals Inc - on track to initiating global Aurora study this quarter
* Aurinia-Confirmatory data that can be generated from aurora trial, aura-lv phase iib study should support regulatory submissions in US, Europe, Japan Source text for Eikon: ID:nBw20H8M4a Further company coverage: AUP.TO